Identification of covalent modifications in P450 2E1 by 1,2-epoxy-3-butene in vitro.
1,3-Butadiene is metabolized mainly by cytochrome P450 2E1 to several epoxides that are considered toxic and carcinogenic. The first step of BD metabolism is oxidation to 1,2-epoxy-3-butene (EB), a reactive metabolite. It has been shown that P450s can be inactivated by covalent binding of reactive metabolites to protein or heme. Molecular dosimetry studies have clearly shown that BD metabolism follows a supralinear dose response, suggestive of saturation of metabolic activation. In this study, potential binding sites of EB in human P450 2E1 were identified and modeled to test whether EB covalently binds to residues important for enzyme activity. Commercially available human P450 2E1 was reacted with EB, digested with trypsin and the resulting peptides were analyzed by Matrix-Assisted Laser Desorption/Ionization tandem Time-of-Flight mass spectrometry (MALDI-MS). The identity of EB modified peptides was confirmed by Matrix-Assisted Laser Desorption/Ionization tandem mass spectrometry (MALDI-MS/MS) sequencing. It was shown that EB binds to four histidine and two tyrosine residues. All modification sites were assigned by at least two adjacent and a minimum of eight peptide specific fragments. Protein modeling revealed that two of these covalent modifications (His(109), His(370)) are clearly associated with the active site, and that their Calpha atoms are located less than 9A from a known inhibitor binding site. In addition, the side chain of His(370) is within 4A of the heme group and its modification is expected to influence the orientation of the heme. The Calpha atom of Tyr(71) is within 14A of the potential inhibitor binding site and within 7A of the flap undergoing conformational change upon ligand binding, potentially placing Tyr(71) near the substrate as it enters and leaves the active site. The data support the hypothesis that EB can inactivate P450 2E1 by covalent modifications and thus add an additional regulatory mechanism for BD metabolism.
Boysen
Gunnar
G
Department of Environmental Sciences and Engineering, The University of North Carolina, Chapel Hill, NC 27599-7431, USA. gboysen@unc.edu
Scarlett
Cameron O
CO
Temple
Brenda
B
Combs
Terry P
TP
Brooks
Natasha L
NL
Borchers
Christoph H
CH
Swenberg
James A
JA
D000595:Amino Acid Sequence; D000818:Animals; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism*; D004852:Epoxy Compounds / Q000378:metabolism*; D006801:Humans; D013058:Mass Spectrometry; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry; D051381:Rats; D040681:Structural Homology, Protein
D004852:Epoxy Compounds; D010455:Peptides; C024370:3,4-epoxy-1-butene; D019392:Cytochrome P-450 CYP2E1